The National Institutes of Health (NIH) has begun enrolling participants in a clinical trial to test the effectiveness of hydroxychloroquine in treating COVID-19, the agency announced Thursday.

A Phase 1 clinical trial of a novel influenza vaccine has begun inoculating healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. The placebo ...

NIH clinical trial will test precision medicine treatments for myeloid cancers NOTE: A virtual media briefing is scheduled for Tuesday, October 22, 2024, at 11:30 a.m. ET. Details below.